Lead Product(s) : Undisclosed
Therapeutic Area : Dermatology
Study Phase : Discovery
Sponsor : Kubota Vision Inc
Deal Size : Undisclosed
Deal Type : Agreement
Kubota Vision Announces Signing of Open Innovation Agreement with LEO Pharma
Details : Open Innovation Agreement with LEO Pharma A/S will screen novel VAP-1 inhibitor compounds discovered by Kubota Vision.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 16, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Dermatology
Highest Development Status : Discovery
Sponsor : Kubota Vision Inc
Deal Size : Undisclosed
Deal Type : Agreement